Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.135
+0.155 (3.89%)
At close: Nov 21, 2024, 4:00 PM
4.150
+0.015 (0.36%)
After-hours: Nov 21, 2024, 4:22 PM EST
Candel Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 134 | 43 | 52 | 224 | - | - |
| Market Cap Growth | 735.70% | -17.80% | -76.95% | - | - | - |
| Enterprise Value | 129 | 22 | -3 | 137 | - | - |
| Last Close Price | 3.98 | 1.47 | 1.79 | 7.82 | - | - |
| PS Ratio | - | - | 413.76 | 1794.84 | - | - |
| PB Ratio | -14.57 | 3.34 | 1.08 | 3.50 | - | - |
| P/TBV Ratio | - | 3.34 | 1.08 | 3.50 | - | - |
| EV/Sales Ratio | - | - | - | 1092.08 | - | - |
| Debt / Equity Ratio | -1.05 | 1.79 | 0.48 | 0.01 | 0.04 | 0.01 |
| Asset Turnover | - | - | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 1.08 | 2.50 | 12.48 | 15.41 | 7.44 | 31.96 |
| Current Ratio | 1.18 | 2.59 | 12.81 | 15.84 | 7.46 | 32.06 |
| Return on Equity (ROE) | -1344.47% | -125.50% | -33.61% | -80.60% | -53.16% | - |
| Return on Assets (ROA) | -62.08% | -40.36% | -26.01% | -25.22% | -20.51% | - |
| Return on Capital (ROIC) | -95.44% | -45.26% | -32.10% | -35.28% | -25.43% | - |
| Earnings Yield | -39.06% | -89.24% | -36.34% | -16.10% | - | - |
| FCF Yield | -21.47% | -81.63% | -63.26% | -10.72% | - | - |
| Buyback Yield / Dilution | -3.83% | -0.39% | -52.72% | -62.49% | -0.71% | - |
| Total Shareholder Return | -3.83% | -0.39% | -52.72% | -62.49% | -0.71% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.